Parsons (PSN) announced that the company was awarded a biological defense research contract to advance the Naval Medical Research Command’s mission to defend against the threat of biological and chemical warfare. The $24M contract consists of a one-year base period and four one-year option periods. Under this contract, Parsons will continue to support NMRC’s Biological Defense Research Directorate in their efforts to facilitate biological research for the rapid detection of infectious diseases of Department of Defense importance and the enhancement of global disease surveillance for early pathogen detection and response.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSN:
- Parsons selected by Tucson Airport Authority
- Parsons price target lowered to $110 from $130 at BofA
- Strategic Defense Alignment and Opportunistic Share Buybacks Support Buy Rating for Parsons
- Parsons boosts stock repurchase authorization to $250M
- Parsons’ Sealing Technologies awarded prototype agreement from DoD